Terms: = Skin cancer AND SMARCD1, CRACD1, 6602, ENSG00000066117, Rsc6p, BAF60A, Q96GM5 AND Treatment
1 results:
1. Integrated analysis reveals smarcd1 is a potential biomarker and therapeutic target in skin cutaneous melanoma.
Chen J; Yu N; Ou S; Wang X; Li H; Zhu H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11619-11634. PubMed ID: 37401939
[TBL] [Abstract] [Full Text] [Related]
